Salt Lake City, UT – According to filings with the U.S. Securities and Exchange Commission, J3 Bioscience is raising $1,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tyler Mccabe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About J3 Bioscience

J3 Bioscience is a developmental stage women’s health company focused on using its proprietary technologies to create products addressing unmet needs. J3 Bio’s next product in development is a patented, specially formulated pH balancing ring.

To learn more about J3 Bioscience, visit http://j3bio.com/

Contact:
Tyler Mccabe, Chief Executive Officer
801-550-9956
https://www.linkedin.com/in/tyler-mccabe-50bba47/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved